Female Urinary Incontinence Slings Market Analysis | Japan | 2017-2023 | MedCore

  • Year: 2017
  • Scope: 2013-2023
  • Region: Japan
  • Pages: 218
  • Published Date: 5/1/2017
  • Type: MedCore

Product Description

As the sensationalized negative media coverage has dissipated, the use of synthetic slings has begun to stabilize. Although most of the media scrutiny of these devices occurred in the United States, these events adversely affected the Japanese market as well, although not as drastically. Continued decreases in ASP will be offset by the growth in unit sales as procedure numbers continue to recover.

The mid-urethral sling procedure is the most common surgery for incontinence and is a minimallyinvasive, outpatient procedure. Although the mid-urethral procedure has been successful for many women, many national health authorities such as the FDA have issued warnings about the complications and side-effects which have been documented with surgical mesh procedures.

Segments Covered in This Market

  • Synthetic Female Urinary Incontinence Sling Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

The leading competitor in the vaginal sling market was Ethicon, part of the Johnson & Johnson group of companies. Boston Scientific comprises the remaining market share in the female urinary incontinence sling market. Offering pre-pubic, transobturator and retropubic placement, their product portfolop includes the Obtryx® Transobturator Mid-Urethral Sling System Obtryx™ Sling System and Lynx® suprapubic midurethral and Advantage Fit™ Transvaginal Mid-Urethral Sling systems. All systems use Advantage® mesh.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled Japan Market Report Suite for Gynecological Devices – MedSuite

Learn More about these product types

FREE Sample Report

The "Japan Market Report Suite for Gynecological Devices 2017 – MedSuite" includes analysis on the following companies currently active in this market:
Cook Medical
Cooper Surgical
Boston Scientific
Irvine Scientific
Naka Medical
Johnson & Johnson
Karl Storz
Rocket Medical
Medi-Con International
Carl Zeiss
Sankyo Medical
Life Global (IVF Online)
Astec Bio
The Pipette Company
Esco Global
Richard Wolf
Merit Medical Systems
Others include: Nidacon Medical, Reproline Medical, ThermoFisher, AngioDynamics, Welch Allyn, local competitors, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary


Select License Type

Female urinary incontinence affects approximately 10% of the population at some point in their lives. Urinary incontinence affects both women and men; however, there is a greater prevalence of incontinence amongst women. The difference is often attributed to changes that occur during pregnancy and childbirth as well as additional factors such as menopause. There are four main categories recognized for urinary incontinence, with 50% of cases diagnosed as stress urinary incontinence (SUI). Surgical treatment using a urinary incontinence sling is one of the most recommended options to help SUI patients become incontinence-free.

  • 2017
  • 2013-2023
  • Japan
  • 5/1/2017
  • 218
  • MedCore
    Your Cart
    Your cart is emptyReturn to Report Library